Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect.
暂无分享,去创建一个
K. Nakao | T. Tagami | H. Kuzuya | A. Shimatsu | A. Sugawara | N. Satoh | Yoshihiro Ogawa | Kazunori Yamada | S. Kono | T. Usui | H. Uesugi | Hiroyuki Sugiyama